Gates Frontier, LLC - Jul 25, 2025 SCHEDULE 13G Report for Lyell Immunopharma, Inc. Common Stock, $0.0001 par value per share

Filing Manager: Gates Frontier, LLC
Reporting Manager: Gates Frontier, LLC
Security: Lyell Immunopharma, Inc. Common Stock, $0.0001 par value per share
Shares outstanding: 18.6M shares
Disclosed Ownership: 1.04M shares
Ownership: 5.6%
Form type: SCHEDULE 13G
Date filed: 8/1/2025, 04:15 PM
Date of event: Jul 25, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Gates Frontier, LLC	5.6%	1.04M	1.04M	0	/s/ Alan Heuberger	Attorney-in-fact for Michael Larson, Manager
William H. Gates III	5.6%	1.04M	1.04M	0	/s/ Alan Heuberger	Attorney-in-fact